CXCL13 has been proposed as a potential biomarker of activity in SLE and LN [27,28], and CXCL13 and CCL4 were shown to have utility in SLE-related haemolytic anaemia, while their roles in NPSLE remain elusive [29]. This evidence concerns the gene CXCL13 and non-autoimmune hemolytic anemia.